Author: News Room
Dublin, April 02, 2026 (GLOBE NEWSWIRE) — The “Low-Grade Glioma Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The global low-grade glioma market is experiencing a robust growth trajectory, with market size expected to increase from $1.47 billion in 2025 to $1.56 billion in 2026, representing a compound annual growth rate (CAGR) of 5.9%. Several factors have contributed to this surge, including advancements in neuroimaging technologies, improved survival rates for low-grade glioma patients, heightened awareness of brain tumor symptoms, and the expansion of oncology treatment centers. Looking ahead, the market is set to further expand, reaching $1.94 billion by…
Bracken Well at Grasslands Project, 325 km southwest of Lawson Discovery, is successfully cased after being drilled to a total depth of 2,600 meters Mixed gas interval with Helium and Natural Hydrogen encountered in Upper Devonian at Bracken, followed by two Natural Hydrogen-dominant zones in basal Deadwood and Basement Complex; service rig operations for well completion and testing phase to begin after spring breakupLawson “look-a-like” target identified just 12 km southwest of original Lawson Discovery, based on further review of legacy 2D seismic data High quality data set delivered from a 3D Seismic Survey completed on Genesis Trend covering 47 sq.…
Dublin, April 02, 2026 (GLOBE NEWSWIRE) — The “Medulloblastoma Drug Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights, covering market size, regional shares, competitor analysis, and trends. The global medulloblastoma drug market has experienced significant growth, with projections indicating a surge from $3.03 billion in 2025 to $3.28 billion in 2026, maintaining a robust compound annual growth rate (CAGR) of 8.3%. This expansion is driven by advancements in pediatric oncology, increased diagnoses, standardized chemotherapy protocols, the proliferation of cancer hospitals, and improved surgical outcomes. Looking ahead, the market is poised to grow to $4.49…
VICTORIA, Seychelles, April 02, 2026 (GLOBE NEWSWIRE) — MEXC, the world leader in zero‑fee digital asset trading, has listed Mezo (MEZO) in the Innovation Zone and launched the Airdrop+ event, which offers $50,000 in MEZO and 15,000 USDT in rewards. Mezo is a Bitcoin finance application that enables users to access lending, stablecoin, and yield infrastructure while retaining ownership of their BTC. MEZO, the protocol’s native token with a total supply of 1,000,000,000, functions as an incentive and coordination asset within the ecosystem, aligning users, liquidity providers, and validators around Bitcoin-based financial activity. The Mezo Airdrop+ event runs through April…
VICTORIA, Seychelles, April 02, 2026 (GLOBE NEWSWIRE) — MEXC, the world leader in zero‑fee digital asset trading, announced the launch of the industry-first VVIP system, set to go live on April 2, 2026, at 10:00 UTC. The system redefines VVIP access by moving beyond traditional asset-based eligibility toward a dynamic, multi-dimensional user value-based model. It gives every trader the opportunity to access elite privileges and lays the foundation for a more user-centric ecosystem. At the core of the VVIP system is M-Score, a dynamic metric that reflects user value based on trading activity, account security, and platform engagement. Unlike conventional…
Ontario’s attorney general will neither condemn nor support Premier Doug Ford’s suggestion that a provincial judge should apologize for her instructions to the jury in the trial of Umar Zameer. The high-profile case saw Zameer acquitted of first-degree murder in the death of Det. Const. Jeffrey Northrup, a plainclothes officer who was fatally run over in downtown Toronto in the summer of 2021.During the case, the judge called into question the testimony of three central witnesses — all Toronto police detectives — in the Crown’s argument, suggesting they lied and colluded.Then, last month, an Ontario Provincial Police investigation into the…
Dublin, April 02, 2026 (GLOBE NEWSWIRE) — The “Pediatric Neuroblastoma Treatment Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The report provides a detailed analysis of market size, regional shares, competitor strategies, and trends. The pediatric neuroblastoma treatment market has demonstrated substantial growth, increasing from $2.02 billion in 2025 to a projected $2.2 billion in 2026, at a CAGR of 9%. Historical growth factors include limited access to oncology drugs, low adoption of immunotherapy, reliance on conventional chemotherapy, limited specialized centers, and fragmented clinical data. Looking forward, the market is expected to reach $3.13 billion by 2030, growing at…
VICTORIA, Seychelles, April 02, 2026 (GLOBE NEWSWIRE) — MEXC, the world leader in zero‑fee digital asset trading, will list the fourteenth batch of Ondo tokenized stock trading pairs on its spot market, as part of its ongoing collaboration with Ondo Finance. The latest additions include tokenized exposure to Plug Power, iShares MSCI South Korea ETF, and iShares MSCI Japan ETF, broadening the range of assets available to users across different sectors and markets directly on the MEXC platform. The three pairs — PLUGON/USDT, EWYON/USDT, and EWJON/USDT — are scheduled to list on April 2, 2026, at 12:00 UTC. Deposits will open…
TORONTO – The disappointment in RJ Barrett’s face was evident. The Mississauga, Ont., native blankly stared at the statsheet, taking his time before getting his thoughts out. When he walked out of the press conference, he mumbled while shaking his head in disgust.Barrett led the Toronto Raptors with 20 points in a 123-115 loss to the lowly Sacramento Kings on Wednesday night. The Kings entered the game tied for the NBA’s worst road record at 6-32, while also having the league’s fourth-worst record.“We’ve been doing well. We have a solid record, but it’s nights like these where this is a…
Dublin, April 02, 2026 (GLOBE NEWSWIRE) — The “Glioblastoma Multiforme (GBM) Treatment Market Report 2026” has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive insight into market size, regional shares, competitive analysis, and emerging trends. The glioblastoma multiforme (GBM) treatment market size is on a steep growth trajectory, rising from $2.73 billion in 2025 to $3.02 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. This surge largely results from limited survival outcomes, reliance on surgery and radiation, and the standardization of chemotherapy. The market’s historic expansion is also fueled by the proliferation of neuro-oncology centers…